arrow
C

Chiara Maria Grana

European Institute of Oncology
H指数:43
被引数:6,478

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

[177Lu]Lu-edotreotide与依维莫司治疗胃肠胰神经内分泌肿瘤的比较(COMPETE研究):一项III期、多中心、随机、开放标签、优效性试验

2026-07-020
PRE
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [177Lu]Lu-DOTA-TATE: A post-authorisation safety study

LysaKare输注对接受[177Lu]Lu-DOTA-TATE治疗的可治疗性胃肠胰神经内分泌肿瘤患者血清钾水平的影响:一项上市后安全性研究

2026-04-130
OA
Prognostic implications of [18F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study

[18F]FDG PET及代谢变化在经再次挑战PRRT治疗的晚期神经内分泌肿瘤患者中的预后意义:10年生存WARMTH研究的最终结果

2026-01-011
PRE
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management

神经内分泌肿瘤骨转移:一项关于自然史和管理的意大利全国性调查结果

2025-11-180
OAAI
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期GEP-NENs的管理临床实践指南:意大利医学肿瘤学会(AIOM)与意大利神经内分泌肿瘤学会(ITANET)合作,采用GRADE方法进行证据评估和推荐。

2025-11-120
OAAI
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy

AIMN, ITANET, SIE 联合立场文件:关于肽受体放射性核素治疗期间神经内分泌肿瘤类癌综合征及其危象的识别、预防和管理的联合立场文件

2025-10-070
OA
Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial

[177Lu]Lu-DOTATATE在晚期中肠神经内分泌肿瘤患者中的剂量测定:来自III期NETTER-1试验子研究的结果

2025-02-131
PRE
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
2024-10-122
OAAI
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma
2024-09-012
PRE
Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study
2024-05-220
OAAI